These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10716127)

  • 1. Haematological abnormalities in rheumatic mitral valve disease.
    Knight CJ
    Int J Cardiol; 2000 Feb; 72(3):207-8. PubMed ID: 10716127
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemostasis and the rheologic properties of the blood in patients with rheumatic mitral stenosis].
    Dziak GV; Vulykh NV
    Vrach Delo; 1989 Jul; (7):82-4. PubMed ID: 2800514
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood rheology and central hemodynamics in rheumatic mitral valve diseases].
    Murashko VV; Dzhanashiia PKh; Shardanov NA; Kaĭdash AN; Khurtsilava SG
    Revmatologiia (Mosk); 1983; (2):26-9. PubMed ID: 6353510
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to Editor.
    Şahan E; Şahan S
    Indian Heart J; 2017; 69(6):808. PubMed ID: 29174269
    [No Abstract]   [Full Text] [Related]  

  • 5. High sensitive C-reactive protein and interleukin 6 in atrial fibrillation with rheumatic mitral stenosis from Indian cohort.
    Sharma G; Shetkar S; Bhasin A; Ramakrishnan L; Juneja R; Naik N; Roy A; Ramakrishnan S; Bhargava B; Bahl VK
    Indian Heart J; 2017; 69(4):505-511. PubMed ID: 28822519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma endothelin-1 levels in patients with rheumatic mitral stenosis and a history of cerebral thromboembolism.
    Ma LC; Chen MC; Chang HW
    Chang Gung Med J; 2004 Nov; 27(11):794-800. PubMed ID: 15796254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
    Cevik C; Otahbachi M; Nugent K; Ozkan M
    J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in plasma TXB2 and 6-keto-PGF1 alpha and left atrial thrombosis in mitral stenosis].
    Cai W
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Apr; 18(2):98-100, 127. PubMed ID: 2209410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double giant thrombi in the left atrium in a patient with rheumatic mitral valve stenosis and atrial fibrillation.
    Akcay M; Gulel O; Bahcivan M; Yuksel S
    Eur J Cardiothorac Surg; 2013 Dec; 44(6):1150. PubMed ID: 23671200
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation.
    Shang YP; Lai L; Chen J; Zhang F; Wang X
    J Heart Valve Dis; 2005 Jul; 14(4):453-9. PubMed ID: 16116870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated platelet microparticle levels in valvular atrial fibrillation.
    Azzam H; Zagloul M
    Hematology; 2009 Dec; 14(6):357-60. PubMed ID: 19941743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous transluminal mitral valvuloplasty reduces circulating vascular cell adhesion molecule-1 in rheumatic mitral stenosis.
    Chen MC; Chang HW; Juang SS; Yip HK; Wu CJ; Yu TH; Cheng CI
    Chest; 2004 Apr; 125(4):1213-7. PubMed ID: 15078727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of insulin-like growth factor-1 (IGF-I) level in patients with rheumatic mitral stenosis.
    Deveci OS; Yavuz B; Sen O; Deniz A; Ozkan S; Dal K; Ata N; Baser S; Akin KO; Kucukazman M; Beyan E; Ertugrul DT
    Cardiol Young; 2015 Mar; 25(3):496-500. PubMed ID: 24625682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal mitral valvuloplasty reduces circulating soluble CD40 ligand in rheumatic mitral stenosis.
    Chen MC; Chang HW; Wu CJ; Yang CH; Hung WC; Yeh KH; Fu M
    Chest; 2005 Jul; 128(1):36-41. PubMed ID: 16002913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased mean platelet volume in rheumatic mitral stenosis: a possible factor for thromboembolic events.
    Yavuz B; Ertugrul DT; Yalcin AA; Kucukazman M; Ata N; Dal K
    J Cardiol; 2009 Apr; 53(2):204-7. PubMed ID: 19304123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin production in mitral stenosis.
    Yamamoto K; Ikeda U; Shimada K
    N Engl J Med; 1993 Dec; 329(23):1740-1. PubMed ID: 8232475
    [No Abstract]   [Full Text] [Related]  

  • 17. A Clinical Evaluation of Atrial Fibrillation in Rheumatic Heart Disease.
    Sharma SK; Verma SH
    J Assoc Physicians India; 2015 Jun; 63(6):22-5. PubMed ID: 26710395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial platelet activity with rheumatic mitral stenosis: correlation study of severity and platelet P-selectin expression by flow cytometry.
    Chen MC; Wu CJ; Yip HK; Chang HW; Fang CY; Yu TH; Fu M
    Chest; 2003 Nov; 124(5):1663-9. PubMed ID: 14605032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous mitral balloon valvuloplasty reduces mean platelet volume in patients with rheumatic mitral stenosis.
    Erdogan D; Icli A; Aksoy F; Yucel H; Ozaydin M; Dogan A; Goktekin O
    Scand J Clin Lab Invest; 2012 Oct; 72(6):452-8. PubMed ID: 22697175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balance between plasma levels of tumor necrosis factor-alpha and interleukin-10 in rheumatic mitral stenosis.
    Chen MC; Chang HW; Wu CJ; Yang CH; Yu TH; Chen CJ; Hung WC
    Cardiology; 2005; 104(4):171-5. PubMed ID: 16155388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.